Jonathan Yong
Stock Analyst at UBS
(2.64)
# 2,243
Out of 5,090 analysts
96
Total ratings
61.11%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Sell | $11 → $12 | $16.77 | -28.44% | 9 | Nov 7, 2025 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $3.81 | +31.23% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.58 | +16.28% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.33 | +28.62% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.71 | +195.20% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.00 | +225.00% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $39.20 | -64.29% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.62 | +30.40% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $14.91 | +114.62% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $16.26 | +545.76% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $112.50 | -28.89% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $258.39 | -10.60% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.59 | +255.73% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $198.83 | -49.71% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $808.62 | -44.35% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.46 | +387.80% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.01 | +1,645.64% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $18.88 | -9.96% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $151.86 | +130.48% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $15.47 | +514.09% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $3.03 | +180.53% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.84 | +71.98% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $2.59 | +556.37% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.57 | +138.10% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $75.90 | +11.99% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $182.51 | -20.00% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $38.34 | +176.47% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $231.08 | -32.06% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $265.44 | +38.64% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $257.85 | +146.27% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $75.63 | +54.70% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $22.12 | +35.62% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $486.70 | -38.77% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $210.00 | -54.76% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $330.91 | +49.59% | 1 | Oct 15, 2021 |
Oscar Health
Nov 7, 2025
Maintains: Sell
Price Target: $11 → $12
Current: $16.77
Upside: -28.44%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $3.81
Upside: +31.23%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.58
Upside: +16.28%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.33
Upside: +28.62%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.71
Upside: +195.20%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.00
Upside: +225.00%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $39.20
Upside: -64.29%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.62
Upside: +30.40%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $14.91
Upside: +114.62%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $16.26
Upside: +545.76%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $112.50
Upside: -28.89%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $258.39
Upside: -10.60%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.59
Upside: +255.73%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $198.83
Upside: -49.71%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $808.62
Upside: -44.35%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.46
Upside: +387.80%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.01
Upside: +1,645.64%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $18.88
Upside: -9.96%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $151.86
Upside: +130.48%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $15.47
Upside: +514.09%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $3.03
Upside: +180.53%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.84
Upside: +71.98%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $2.59
Upside: +556.37%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.57
Upside: +138.10%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $75.90
Upside: +11.99%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $182.51
Upside: -20.00%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $38.34
Upside: +176.47%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $231.08
Upside: -32.06%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $265.44
Upside: +38.64%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $257.85
Upside: +146.27%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $75.63
Upside: +54.70%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $22.12
Upside: +35.62%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $486.70
Upside: -38.77%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $210.00
Upside: -54.76%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $330.91
Upside: +49.59%